Welcome to the AstraZeneca Open Innovation Pavilion, where InnoCentive Solvers are invited to join forces to deliver meaningful new medicines to previously untreatable medical challenges. Patients that suffer unite us to action – partner with us, let us partner with you, to explore novel therapies for those in need.
Mission / Overview
AstraZeneca is a Global Biopharmaceutical Company with Research and Development at its Core. The global healthcare environment is changing at a rapid pace. Healthcare is becoming more personalized, treatments are becoming more targeted, and economic pressures mean governments and healthcare systems are demanding increasingly cost-effective solutions to healthcare problems.
Our ultimate mission is to make a difference through our medicines for patients, their families and society in general. We believe that scientific research is the key to achieving this, in collaboration with others who share our interest and our passion.
Our Open Innovation Goals and Resources Available
Although AstraZeneca has extensive expertise in biopharmaceutical research and development, we recognize that great ideas come from many sources. In fact, most biomedical innovation occurs outside company walls. Thus, we believe that we stand a much better chance of delivering meaningful treatments for serious diseases like Alzheimer’s, cancer and diabetes if we collaborate and share knowledge and resources with other scientists and organizations rather than work in isolation.
You are invited to view and participate in our InnoCentive Challenges, please click on the Challenges tab for more information. In addition to the InnoCentive Challenges, we are seeking to collaborate with partners across all stages of drug discovery – from the early idea through to early clinical development. These partnerships could profit from the exchange of compounds, technology and/or knowledge to provide an extra gear to hasten and augment the research. For our partners and collaborators, working with AstraZeneca means access to optimized compounds, compound libraries, technologies, multi-disciplinary science, services and know-how, with the prospect of joint publications in high profile journals and, most importantly, the opportunity to see their ideas develop into treatments for patients.
We have created the AstraZeneca Open Innovation platform to help use identify and establish mutually beneficial collaborations that will lead to the discovery and development of new medicines. It provides a robust but simple process for us to link our expertise, experience, resources and technology with those of external experts and to explore prospective partnerships that accelerate the advancement of medical science and breakthrough therapies for patients.
Building on a solid record of open collaborations, AstraZeneca is seeking opportunities to work with like-minded scientists in academia and organizations with a passion for medical research and with the common goal of discovering and developing novel medicines for the treatment of patients with diseases of high unmet need.